SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells
- 1 July 1986
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 12 (7), 1239-1242
- https://doi.org/10.1016/0360-3016(86)90267-1
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Radiosensitization of hypoxic cells in vivo by SR 2508 at low radiation doses: A preliminary reportInternational Journal of Radiation Oncology*Biology*Physics, 1984
- The hypoxic tumor cell: A target for selective cancer chemotherapyBiochemical Pharmacology, 1980
- Combination therapy with radiation and mitomycin C: Preliminary results with EMT6 tumor cells in vitro and in vivoInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Mode of Action of Quindoxin and Substituted Quinoxaline-di- N -Oxides on Escherichia coliAntimicrobial Agents and Chemotherapy, 1978
- Radiosensitizing and Toxic Effects of the 2-Nitroimidazole Ro-07-0582 in Hypoxic Mammalian CellsRadiation Research, 1976
- Hypoxic Sensitizers: Radiobiological Studies at the Cellular LevelRadiology, 1975
- Potential bioreductive alkylating agents. 1. Benzoquinone derivativesJournal of Medicinal Chemistry, 1972
- Simple Synthesis of 3‐Amino‐1,2,4‐benzotriazine 1,4‐DioxideAngewandte Chemie-International Edition, 1972
- The Phenomenon of Reoxygenation and Its Implications for Fractionated RadiotherapyRadiology, 1972
- 623. Polyazabicyclic compounds. Part II. Further derivatives of benzo-1 : 2 : 4-triazineJournal of the Chemical Society, 1957